Although recognized as a tumor suppressor factor for healthy cells and early-stage cancer cells, in late-stage cancer TGF-β becomes the archetype of the tolerogenic tumor milieu, by primarily controlling the commitment and effector functions of immune cell subsets within the TME [102,103]. Here, TGFB1 is linked to cancer.